The correlation of echocardiographic findings with BNP, blood uric acid and CPR in OSAS patients with manifest right cardiac pathologies Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012
The influence of right ventricular diastolic functions and pulmonary hypertension on exercise limitation and their relationship with serum NT-proBNP levels in COPD Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease Year: 2011
Relationship between plasma NT-proBNP level and cardiovascular complications in obstructive sleep apnoea (OSA) patients Source: Annual Congress 2010 - Nocturnal cardiology: chronic heart failure, acute chest syndrome, coronary artery disease and collagen vascular disease Year: 2010
proBNP is not elevated in patients with advanced COPD and normal left cardiac function Source: Eur Respir J 2007; 30: Suppl. 51, 707s Year: 2007
Relationship between NT-proBNP level, echocardiographic parameters and cardiovascular diseases in patients with obstructive sleep apnoea (OSA) Source: Annual Congress 2012 - Physiology, obesity and the downstream effects of OSA Year: 2012
Comparison of NT-proBNP and BNP in the diagnosis of pulmonary hypertension – influence of renal impairment Source: Eur Respir J 2006; 28: Suppl. 50, 425s Year: 2006
Relationship between NT-proBNP plasma level and nocturia in obstructive sleep apnoea (OSA) patients Source: Annual Congress 2007 - Systemic effects of obstructive sleep apnoea Year: 2007
Measurements of urine leptin levels in OSA patients Source: Eur Respir J 2003; 22: Suppl. 45, 90s Year: 2003
Effect of continuous positive airway pressure treatment on elevated levels of C-reactive protein in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 330s Year: 2004
Relationships between elevated cardiac troponin levels in COPD exacerbations and subsequent cardiac investigation and management Source: Annual Congress 2011 - COPD exacerbation Year: 2011
Evaluation of long-term effect of continuous positive airway pressure (CPAP) therapy on reduction of high sensitivity C-reactive protein (HSCRP) for patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2005; 26: Suppl. 49, 357s Year: 2005
Positive effect of CPAP therapy in OSA patients on A-FABP, CRP and triacylglycerols levels and diastolic blood pressure Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012
Effect of noninvasive ventilation (NIV) on left ventricular (LV) function, B-type natriuretic peptide (BNP) and markers of systemic inflammation in patients with refractory heart failure Source: Eur Respir J 2006; 28: Suppl. 50, 188s Year: 2006
Serum vitamin D levels in patients with obstructive sleep apnea syndrome and concentration changes after continuous positive airway pressure treatment Source: Virtual Congress 2020 – Treatment of obstructive sleep apnoea and its effects Year: 2020
NT-proBNP correlates with RVEF in patients suffering from pulmonary arterial hypertension Source: Eur Respir J 2004; 24: Suppl. 48, 110s Year: 2004
Echocardiography and N-terminal-pro-brain natriuretic peptide in assessment of left ventricular diastolic dysfunction in stable COPD in relation to disease severity Source: International Congress 2017 – Current challenges in COPD evaluation Year: 2017
Effect of continuous positive airway pressure on plasma B-type natriuretic peptide in patients with respiratory failure and left ventricular dysfunction complicating acute myocardial infarction Source: Annual Congress 2006 - Acute respiratory failure: diagnostic procedures and clinical management Year: 2006
Association between plasma leptin levels and obstructive sleep apnoea in non-obese patients with coronary artery disease and response to CPAP treatment Source: International Congress 2019 – Impact of sleep-disordered breathing in other diseases Year: 2019
The relationship of plasma adropin levels in pediatric obese patients with OSA Source: International Congress 2019 – New developments in sleep-disordered breathing, gas exchange and lung function in children Year: 2019
3 month continuous positive airway pressure (CPAP) therapy decreases serum lipids, but not homocysteine and leptin concentration in patients with OSAS Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea Year: 2009